Article info

Original research
Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer

Authors

  • Miok Kim Therapeutics & Biotechnology Division, Drug Discovery Platform Research Center, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea PubMed articlesGoogle scholar articles
  • Yong Ki Min Therapeutics & Biotechnology Division, Drug Discovery Platform Research Center, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea PubMed articlesGoogle scholar articles
  • Jinho Jang Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Republic of KoreaKorean Genomics Center, UNIST, Ulsan, Republic of Korea PubMed articlesGoogle scholar articles
  • Hyejin Park Therapeutics & Biotechnology Division, Drug Discovery Platform Research Center, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea PubMed articlesGoogle scholar articles
  • Semin Lee Department of Biomedical Engineering, Ulsan National Institute of Science and Technology, Ulsan, Republic of KoreaKorean Genomics Center, UNIST, Ulsan, Republic of Korea PubMed articlesGoogle scholar articles
  • Chang Hoon Lee Therapeutics & Biotechnology Division, Drug Discovery Platform Research Center, Korea Research Institute of Chemical Technology, Daejeon, Republic of Korea PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Chang Hoon Lee; redmour0{at}gmail.com; Professor Semin Lee; seminlee{at}unist.ac.kr
View Full Text

Citation

Kim M, Min YK, Jang J, et al
Single-cell RNA sequencing reveals distinct cellular factors for response to immunotherapy targeting CD73 and PD-1 in colorectal cancer

Publication history

  • Accepted June 14, 2021
  • First published July 12, 2021.
Online issue publication 
July 12, 2021
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.